Literature DB >> 9648914

Selective modulation of MAP kinase in embryonic palate cells.

M B Potchinsky1, M R Lloyd, W M Weston, R M Greene.   

Abstract

Murine embryonic palate mesenchyme (MEPM) cells are responsive to a number of endogenous factors found in the local embryonic tissue environment. Recently, it was shown that activation of the cyclic AMP (cAMP) or the transforming growth factor beta (TGFbeta) signal transduction pathways modulates the proliferative response of MEPM cells to epidermal growth factor (EGF). Since the mitogen-activated protein kinase (MAPK) cascade is a signal transduction pathway that mediates cellular responsiveness to EGF, we examined the possibility that several signaling pathways which abrogate EGF-stimulated proliferation do so via the p42/p44 MAPK signaling pathway. We demonstrate that EGF stimulates MAPK phosphorylation and activity in MEPM cells maximally at 5 minutes. Tyrosine phosphorylation and activation of MAPK was unaffected by treatment of MEPM cells with TGFbeta or cholera toxin. Similarly, TGFbeta altered neither EGF-induced MAPK tyrosine phosphorylation nor activity. However, the calcium ionophore, A23187, significantly increased MAPK phosphorylation which was further increased in the presence of EGF, although calcium mobilization reduced EGF-induced proliferation. Despite the increase in phosphorylation, we could not demonstrate induction of MAPK activity by A23187. Like EGF, phorbol ester, under conditions which activate PKC isozymes in MEPM cells, increased MAPK phosphorylation and activity but was also growth inhibitory to MEPM cells. The MEK inhibitor, PD098059, only partially abrogated EGF-induced phosphorylation. Likewise, depletion of PKC isozymes partially abrogated EGF-induced MAPK phosphorylation. Inhibition of both MEK and PKC isozymes resulted in a marked decrease in MAPK activity, confirming that EGF uses multiple pathways to stimulate MAPK activity. These data indicate that the MAPK cascade does not mediate signal transduction of several agents that inhibit growth in MEPM cells, and that there is a dissociation of the proliferative response and MAP kinase activation. Furthermore, other signaling pathways known to play significant roles in differentiation of palatal tissue converge with the MAPK cascade and may use this pathway in the regulation of alternative cellular processes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9648914     DOI: 10.1002/(SICI)1097-4652(199808)176:2<266::AID-JCP5>3.0.CO;2-M

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

1.  Molecular profiles of mitogen activated protein kinase signaling pathways in orofacial development.

Authors:  Saurabh Singh; Xiaolong Yin; M Michele Pisano; Robert M Greene
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2007-01

2.  Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue.

Authors:  D R Warner; M M Pisano; R M Greene
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-01       Impact factor: 2.416

3.  Divergence of epidermal growth factor - transforming growth factor beta signaling in embryonic orofacial tissue.

Authors:  Vasker Bhattacherjee; Robert M Greene; M Michele Pisano
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 May-Jun       Impact factor: 2.416

4.  Arsenate-induced apoptosis in murine embryonic maxillary mesenchymal cells via mitochondrial-mediated oxidative injury.

Authors:  Saurabh Singh; Robert M Greene; M Michele Pisano
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-01

5.  DNA hypermethylation of Fgf16 and Tbx22 associated with cleft palate during palatal fusion.

Authors:  Xuan Shu; Zejun Dong; Liuhanghang Cheng; Shenyou Shu
Journal:  J Appl Oral Sci       Date:  2019-10-07       Impact factor: 2.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.